Nicox to Present at the Glaucoma 360 New Horizons Forum
January 31, 2019
[vc_row][vc_column][vc_column_text]Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that Tomas Navratil, PhD, Executive Vice President, Head of Development, will present at the Glaucoma 360 New Horizons Forum hosted by the Glaucoma Research Foundation on February 1st, 2019 at 1:22 PM PST. Dr. Navratil will present in the session on New Horizons in Drugs and Drops.
The conference is being held at The Palace Hotel, San Francisco.[/vc_column_text][/vc_column][/vc_row]